FBXO32 and cancer: Although the detection limitation exists, these data suggest that factors other than Atrogin-1 and Murf-1 also could be involved in muscle atrophy and that the suppression of KIAA0930 in cancers may alleviate muscle atrophy without changes in the expression levels of cytokines/chemokines.